Protalix BioTherapeutics
PLX
#8500
Rank
S$0.22 B
Marketcap
$3.04
Share price
2.30%
Change (1 day)
46.85%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.13

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.14. In 2022 the company made an earnings per share (EPS) of -$0.41 an increase over its 2021 EPS that were of -$0.85.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.13-132.34%
2022-$0.41-51.61%
2021-$0.85342.86%
2020-$0.19-88.71%
2019-$1.70-34.74%
2018-$2.60-70.92%
2017-$8.952153.35%
2016-$0.40-146.77%
2015$0.85-287.88%
2014-$0.4510%
2013-$0.41130.77%
2012-$0.18-56.67%
2011-$0.41-46.43%
2010-$0.7736.59%
2009-$0.5632.26%
2008-$0.42-93.4%
2007-$6.441298.53%
2006-$0.46-96.59%
2005-$13.5019.32%
2004-$11.321552.65%
2003-$0.68-0%
2002-$0.68-50%
2001-$1.37233.33%
2000-$0.41-84.21%
1999-$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.88-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.55 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.74-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel